A complete range of therapies to treat Macular Degeneration
The Yorkshire Eye Hospital is delighted to announce the arrival of a range of revolutionary new treatments for macular degeneration, one of the most common causes of sight loss in the UK today.
Drugs which act to chemically stop one of the main triggers for new blood vessel growth in the eye are known to be very effective in improving vision and halting sight deterioration. The Yorkshire Eye Hospital is now able to provide a full range of ‘anti VEGF’ treatments (vascular endothelial growth factor) which work by targeting a certain protein. These drugs represent a quantum leap forward in the ability to manage the devastating condition of macular degeneration.
The Yorkshire Eye Hospital is the only independent hospital in Yorkshire able to provide a fully integrated AMD service, supported by fluorescein angiography. This gives us the flexibility to deliver ‘one stop’ diagnosis and treatment. We are proud to be the first in the Yorkshire region to provide this comprehensive range of therapies for patients and fully expect this service to complement and support macular degeneration services in the NHS both now and in the future. Ageing changes at the back of the eye (AMD) involve the part of the eye responsible for central vision. This is the portion of vision that we use when looking directly at something. This part of vision is extremely important for tasks such us reading, recognising faces and watching television. The part of the eye responsible for central vision is the central part of the retina, called the macula. The retina is a thin layer of tissue that lines the inside of the back of the eye. If the eye is likened to a camera then the retina is equivalent to the film in the camera.
What is "WET" AMD
Types of Wet AMD
Treatment Options - Wet
Treatment Options - Dry
Anti VEGF Therapies
Amsler Grid - Macular Test
 |
| B08000603 |
